US20070265642A1 - Patent foramen ovale (PFO) closure method and device - Google Patents
Patent foramen ovale (PFO) closure method and device Download PDFInfo
- Publication number
- US20070265642A1 US20070265642A1 US11/796,937 US79693707A US2007265642A1 US 20070265642 A1 US20070265642 A1 US 20070265642A1 US 79693707 A US79693707 A US 79693707A US 2007265642 A1 US2007265642 A1 US 2007265642A1
- Authority
- US
- United States
- Prior art keywords
- tissue
- septum
- pfo
- septum secundum
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0644—Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00579—Barbed implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00615—Implements with an occluder on one side of the opening and holding means therefor on the other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
Definitions
- the invention relates to occlusion devices and methods for the closure of physical anomalies, like septal apertures, such as patent foramen ovale and other septal and vascular defects.
- a patent foramen ovale as shown in FIG. 1 , is a persistent, one-way, usually flap-like opening in the wall between the right atrium 10 and left atrium 12 of the heart. Since left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap typically stays closed. Under certain conditions, however, RA pressure can exceed LA pressure creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. In utero, the foramen ovale serves as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two over-lapping layers of tissue: septum primum 14 and septum secundum 16 . However, a PFO has been shown to persist in a number of adults.
- a PFO has no therapeutic consequence in otherwise healthy adults.
- patients suffering a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another cause of ischemic stroke are considered for prophylactic medical therapy to reduce the risk of a recurrent embolic event.
- TIA transient ischemic attack
- These patients are commonly treated with oral anticoagulants, which have the potential for adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs.
- Nonsurgical closure of PFOs has become possible with the advent of umbrella devices and a variety of other similar mechanical closure designs, developed initially for percutaneous closure of atrial septal defects (ASD). These devices allow patients to avoid the potential side effects often associated with anticoagulation therapies.
- septal closure devices present such drawbacks as technical complexity of implantation procedure, high complication rates (thrombus, fractures, conduction system disturbances, perforations, residual leaks), high septal profile, large masses of foreign material, and lack of anatomic conformability especially to the PFO flap-like anatomy, as most were originally designed to close ASD's, which are true holes. Additionally, some septal closure devices are complex to manufacture, which can result in lack of consistency in product performance.
- the present invention provides a method of closing two overlapping layers of tissue in a mammalian heart, e.g., a patent foramen ovale (PFO), using a closure device that applies a compressive force to at least one of the layers of tissue.
- the closure device may be retrievable, such that it may be removed after a period of time sufficient to allow the overlapping layers of tissue to fuse together. If necessary to sufficiently close the length of the layers of tissue, multiple closure devices may be administered.
- the closure devices may be delivered with a catheter capable of puncturing mammalian tissue in at least one location.
- the closure device of the present invention may take a number of different forms.
- the closure device may have first and second ends, both of which may be capable of puncturing mammalian tissue.
- the device may be a structure such as a ring with a gap, a folded ring, at least one grappling hook member joined to at least one curved arm by a joinder member, opposed grappling hook members joined by a central connecting member, a grappling hook member and a central connecting member, or a closure device anchor joined to a structure of sufficient diameter to hold the device in place against the overlapping layers of tissue.
- the closure device is sized and shaped such that it extends from septum secundum in the left atrium, into the left atrium, through septum primum, into the right atrium, and to septum secundum in the right atrium.
- Some retrievable devices include elongate tethers to facilitate their removal. Each of these devices has certain advantages, and one skilled in the art will be capable of selecting the device appropriate for a given application.
- the ends of the closure device may also take a number of different forms.
- at least one end may form a disc or a closure device anchor, such as a coil, hook, or corkscrew.
- a closure device anchor such as a coil, hook, or corkscrew.
- These end structures help to maintain the device in place.
- One of the ends, for example the second end may take the form of a knot or a structure similarly capable of holding the device in place and applying a sufficient compressive force to the overlapping layers of tissue.
- the end structure may be adjusted to alter the compressive force applied to the overlapping layers of tissue.
- either or both of the first and second ends may be capable of puncturing mammalian tissue.
- the first end of the device is a septal puncture needle.
- Some closure devices according to the present invention are intended to puncture septum primum upon insertion into the heart.
- such a device may be inserted into the right atrium of the heart and puncture septum primum to enter the left atrium of the heart.
- the first end of the device may simply be deployed into the left atrium, or the first end of the device may be deployed into the left atrium and at least partially puncture septum secundum.
- the first end may be embedded in septum secundum or may completely puncture septum secundum such that the first end extends into the right atrium.
- the second end of the device may then be positioned against septum secundum in the right atrium, thereby providing a compressive force to the septal tissues.
- the second end is also positioned in the left atrium while another portion of the device, such as a fold, is positioned in the right atrium, thereby compressing the septal tissues between the device.
- some closure devices according to the present invention are intended to be inserted between the overlapping layers of tissue, e.g. through the PFO tunnel, to enter the left atrium.
- the first end of the device is then deployed in the left atrium and the second end of the device is deployed in the right atrium, thereby providing a compressive force to the septal tissue.
- at least one of the ends of the device may partially puncture septum secundum.
- FIG. 1 is a diagrammatic sectional view of a Patent Foramen Ovale (PFO);
- FIG. 2 is a view in side elevation of the PFO closure device with mechanical anchors of the present invention
- FIGS. 3 a , 3 b and 3 c illustrate the steps in the deployment of the PFO closure device of FIG. 2 ;
- FIG. 4 is a view in side elevation of a second embodiment of the PFO closure device with mechanical anchors of the present invention
- FIGS. 5 a , 5 b and 5 c illustrate the steps in the deployment of the PFO closure device of FIG. 4 ;
- FIG. 6 is a view in side elevation of a catheter and septal puncture needle used to pierce septum primum;
- FIG. 7 is a view in side elevation of a needle anchor for PFO closure
- FIG. 8 is a view in side elevation of a suture and anchor used for PFO closure
- FIG. 9 is a diagram of multiple anchor placement for PFO closure
- FIGS. 10 a , 10 b and 10 c illustrate the steps in the deployment of a rivet and suture type of PFO closure device
- FIGS. 11 a , 11 b , 11 c and lid illustrate the steps in the deployment of a removable PFO closure device
- FIGS. 12 a , 12 b and 12 c illustrate the steps in the deployment of a multiple hook PFO closure device
- FIG. 13 is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention.
- FIG. 14 is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention.
- FIGS. 15 a , 15 b , and 15 c are an end face view from the right atrium, an end face view from the left atrium, and a side elevation view, respectively, of the deployed alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention.
- a PFO closure device with mechanical anchors indicated generally at 18 includes opposed grappling hook members 20 and 22 connected by a central connecting member 24 .
- the grappling hook members 20 and 22 each include two or more curved hooks.
- three curved hooks 26 , 28 and 30 form the grappling hook member 20 and three curved hooks 32 , 34 and 36 form the grappling hook member 22 .
- the grappling hooks 26 , 28 , 30 , 32 , 34 , and 36 extend radially from the central connecting member 24 .
- the grappling hooks of grappling hook members 20 and 22 have the same geometry but are rotated such that each grappling hook of grappling hook member 20 is situated precisely between two opposed grappling hooks of grappling hook member 22 .
- the angle between any two grappling hooks of grappling hook members 20 and 22 may be determined by the formula 360°/(number of hooks per grappling hook member). To fit within a catheter, these hooks may all be straightened outwardly and compressed to lie along the longitudinal axis of the central connecting member 24 . In this form, the PFO closure device extends longitudinally within a catheter 38 .
- the catheter 38 is inserted from the right atrium 10 through the PFO tunnel, i.e. between septum primum 14 and septum secundum 16 , into the left atrium 12 .
- the grappling hook member 20 is deployed into the left atrium.
- the catheter 38 is drawn back into the right atrium and the grappling hooks 26 , 28 and 30 are drawn back and embedded in the left sides of septum primum and septum secundum.
- the central connecting member 24 extends at an angle through the PFO tunnel permitting septum primum and septum secundum to be drawn to the closed position and secured by the grappling hooks 26 , 28 and 30 .
- the catheter 38 is drawn back to permit the grappling hook member 22 to deploy, and grappling hooks 32 , 34 and 36 pierce the right side of septum primum and septum secundum.
- the grappling hook members 20 and 22 may be formed of flexible, spring-like, bioabsorbable polymer material so as to permit movement from the compressed straight shape to the curved hook shapes following deployment from the catheter 38 .
- the central connecting member 24 may also be formed of bioabsorbable material, such as an absorbable suture material, so the device will ultimately leave no foreign substance in either atrium.
- the grappling hook members 20 and 22 may be formed of spring metal or of a shape memory material, such as nitinol. When the PFO closure device is not formed of bioabsorbable material, it is possible to form the device with only the grappling hook member 20 and a central connecting member 24 so that the device is repositionable and retrievable.
- grappling hooks 26 , 28 , 30 , 32 , 34 and 36 may further include a barb to maintain the device in the septal tissue.
- the grappling hook members 20 and 22 serve as tissue scaffolds, and are covered with a vascular material, such as polyester, biological tissue, bioresorbable polymer, or spongy polymeric material.
- the closure device will conform, at least to some extent, to the septal tissue that it compresses.
- the extent of this conformance depends upon the material from which the device was formed: a device formed of a spring metal or shape memory material will conform to the surrounding septal tissue to a lesser extent than one formed of a flexible, bioabsorbable polymer material.
- FIG. 4 shows a second embodiment of a PFO closure device with mechanical anchors indicated generally at 40 .
- This device when deployed, forms a ring hook design that terminates in two opposed, pointed ends 42 and 44 .
- the device may be straightened to pass through a catheter 38 .
- the catheter is caused to pierce septum primum 14 and enter the left atrium where the pointed end 42 is deployed.
- the catheter is drawn back through septum primum to draw the device through septum primum and embed the pointed end 42 in the left side of septum secundum.
- FIG. 5 b the catheter is drawn back through septum primum to draw the device through septum primum and embed the pointed end 42 in the left side of septum secundum.
- the catheter is withdrawn to fully deploy the PFO closure device and the pointed end 44 is embedded in the right side of septum secundum to compress septum primum and septum secundum together.
- the ring PFO closure device 40 when deployed, may include a gap that is slightly smaller than the thickness of septum secundum into which it is embedded.
- the opposed ends 42 and 44 of the deployed PFO closure device 40 contact each other or overlap.
- closure device 40 may take alternative forms.
- closure devices 90 and 100 are formed as partial rings terminating in two pointed ends 92 and 94 or 102 and 104 and having at least one fold therebetween.
- Closure devices 90 and 100 are deployed in a manner similar to that described above and shown in FIG. 5 .
- the pointed ends 92 and 94 or 102 and 104 puncture the surface of septum secundum exposed in the left atrium and at least one of the folds contacts the surface of septum secundum exposed in the right atrium ( FIGS. 15 a and 15 b ). Septum primum and septum secundum are thus compressed between the pointed ends and at least one of the folds of the device ( FIG. 15 c ).
- PFO closure devices 40 , 90 or 100 can be inserted until the physician is satisfied with the resultant PFO closure.
- the PFO closure devices may be formed of flexible, bioabsorbable polymer material, spring metal, other spring-like non-bioabsorbable material, or shape memory material. The choice of material will affect the degree to which the device conforms to the surrounding septal tissue. As shown in FIGS. 4, 13 , and 14 , the PFO closure device may be a monolithic structure.
- a PFO may also be closed with one or more sutures.
- suture refers to a single connection used to hold two pieces of material or tissue together and need not be a continuous stitch.
- suture refers to a single connection used to hold two pieces of material or tissue together and need not be a continuous stitch.
- to suture a PFO closed has conventionally required the attachment of septum secundum to septum primum with a continuous stitch. This need for a continuous stitch can be eliminated by implanting sutures across the PFO using implantable suture anchors.
- a catheter 46 is used to puncture septum primum and then septum secundum.
- septum primum the puncture creates a hole through which the catheter can pass; in the case of septum secundum, the puncture may be a depression that does not pass through septum secundum.
- a single puncture may be made in septum secundum as shown in FIGS. 6-8 , or, as subsequently described and shown in FIG. 9 , multiple punctures may be made. These punctures are made using a sharp pointed needle tip 48 . Following puncture to a desired depth, the catheter 46 surrounding the needle 48 is withdrawn and the needle component returns (most likely via shape memory) to its predetermined anchor-shape.
- the anchors are most likely fabricated from a shape memory alloy, such as nitinol, although they could be made from a flexible, bioabsorbable polymer or a noble metal, each having their own advantage—no long term implant issues with bioabsorbable anchors and excellent radiopacity with anchors fabricated from a noble metal, such as platinum-iridium.
- the remainder of the suture may be formed of any suitable material, including wire, polymeric materials, and bioabsorbable materials.
- the suturing method includes using a standard septal puncture technique to locate and puncture septum primum. Following this, several approaches exist. One would be that the septal puncture needle would be withdrawn from the catheter and the suturing system then delivered through the catheter (the septal needle catheter would maintain position across septum primum during the exchange). Alternatively, a wire could be placed through the septal needle catheter to maintain position and the suture system could be delivered over the wire, or the septal puncture needle could become part of the suture system. Following delivery of the suture system, the proximal end of the suture may then be tied off so as to secure the system in place and keep the PFO closed. As described below for the rivet design suture system and shown in FIG.
- the proximal end of the suture may be formed into a knot, i.e. the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place.
- Other suitable structures for the proximal end of the suture include, but are not limited to, coils, spirals, and other adjustable mechanisms. This structure should apply sufficient compression to hold septum primum and septum secundum together. The structure may be adjustable, such that the level of compression may be altered as necessary. Multiple sutures may be inserted until the physician is satisfied with the PFO closure.
- a suture 50 is delivered through the septal needle catheter following the removal of the needle.
- a suture catheter 52 enters the left atrium through the septal needle catheter, is pulled back against septum secundum, setting the needle tip(s) 54 deep within it or through it, if it is thin enough.
- the tip could be either radiopaque, echogenic, or both, to be visible by x-ray (fluoroscopy) and/or cardiac echo.
- the constricting system a hypotube or a series of con-axial hypotubes in the embodiment where multiple needles are simultaneously delivered
- the suture anchor 56 is withdrawn, allowing the suture anchor 56 to form into a pre-determined shape tissue anchor, most likely via shape memory properties.
- the anchor 56 on the end of the suture 50 has been embedded in septum secundum and expands to anchor the suture, which passes through septum primum once the suture catheter is removed.
- the anchor shape can be one of many different options, including but not limited to a coil, hook, corkscrew, or grappling hook.
- an anchor can be placed entirely in the right atrium, leaving nothing but suture in the left atrium.
- These anchors may be short strips or cylindrical rods made from a metallic or polymeric material that is biostable or bioabsorbable, or a piece of swellable foam, such as Ivalon.
- the septal needle catheter crosses septum secundum in multiple locations simultaneously.
- the final result as seen from the left atrium in an end face view of septum primum and septum secundum, would be as shown in FIG. 9 , where a plurality of spaced anchors 58 engage septum secundum.
- a rivet design suture system 60 is shown in FIGS. 10 a , 10 b and 10 c .
- a suture 62 and anchor 64 are contained within a catheter 66 , which pierces both septum secundum and septum primum.
- the anchor 64 which is formed of a firm material, such as a metal disc, a small hook (such as the shape memory hooks previously described), or a piece of bio-absorbable polymer, is then deployed into the left atrium, and the suture 62 and catheter 66 are then pulled back as shown in FIG. 10 b to compress the two septa together.
- the suture 62 can then be knotted with knot 68 , as shown in FIG.
- the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place.
- Other suitable structures for the second end of the suture include, but are not limited to, coils, spirals, other adjustable mechanisms. As shown in FIG. 10 c , this structure should apply sufficient compression to hold septum primum and septum secundum together.
- the structure may be adjustable, such that the level of compression may be altered as necessary. Multiple rivet systems can be inserted until a physician is satisfied with the PFO closure.
- the PFO closure device of the present invention may be formed in a manner to facilitate removal once septum primum and septum secundum are fused.
- An exemplary removable PFO closure device 70 is deployed in the manner illustrated by FIGS. 11 a - 11 d .
- the PFO closure device 70 may be delivered by a delivery catheter or sheath 72 and includes a grappling hook member 74 joined to a curved arm 76 by an enlarged tip joinder member 78 . At least one of the grappling hook member and curved arm of the PFO closure device may be curved relative to the other.
- An elongate tether 80 is connected to the tip joinder member 78 and extends back through the catheter 72 .
- the tether 80 can be coated to minimize trauma to the veins.
- the grappling hook member 74 is passed through septum primum 14 ( FIG. 11 b ), and the grappling hook, when free of the catheter, curves in a manner convex relative to the surface of septum secundum and penetrates septum secundum 16 ( FIG. 11 c ). Then, the grappling hook is drawn back toward the catheter by the tether 80 to apply tension to the tissue causing septum secundum to be drawn into contact with septum primum. Then the curved arm 76 is deployed ( FIG. 11 d ) and curves in a manner concave relative to septum secundum so as to engage septum secundum as the catheter is drawn back.
- the compressive force applied by the grappling hook and the curved arm hold septum primum and septum secundum tightly together.
- the grappling hook 74 and curved arm 76 are preferably formed of shape memory material, such as nitinol, so that they respond to body temperature when deployed from the catheter 72 to form the shape shown in FIG. 11 d.
- the catheter 72 is withdrawn and the free end of the tether 80 is attached to a button subcutaneously and allowed to remain in place for a period of time sufficient to allow the two septa to fuse together. Then the device is pulled through septum primum and into a recovery sheath by means of the tether 80 and removed.
- the PFO closure device 70 can be deployed as shown in FIG. 11 without the tether 80 to provide a free standing device with the grappling hook 74 and arm 76 being formed to press the two septa 14 and 16 together.
- the device may later be removed by a removal device, which grabs the joinder member 78 and draws the device through septum primum 14 and into a removal sheath.
- the PFO closure device can include a plurality of opposed grappling hooks and curved arms radially extending in a spaced relationship from the joinder member 78 .
- a device 82 is shown in FIG. 12 .
- the PFO closure device includes a plurality of grappling hooks 84 and a plurality of opposed curved arms 86 which are enclosed in a delivery catheter 72 .
- a small hole 88 is created in septum primum 14 to permit insertion of the catheter into the left atrium and the grappling hooks 84 are deployed as shown in FIG. 12 a . Then, the delivery catheter is drawn back to engage the hooks with both septum secundum and septum primum as shown in FIG.
- the catheter is drawn away to release the curved arms 86 , which engage the two septa in opposed relationship to the grappling hooks 84 .
- the device may have many, e.g. eight, opposed grappling hooks and curved arms.
- the device 82 may be removed by grasping the tip joinder member 78 .
- the device 82 may be permanently deployed by inserting the catheter through the PFO channel between septum secundum and septum primum into the left atrium to deploy the grappling hooks 84 . Then, the catheter is withdrawn back through the PFO channel to release the curved arms 86 .
Abstract
The present invention provides methods and devices for closing two overlapping layers of tissue in a mammalian heart, for example a patent foramen ovale (PFO). The closure devices may take a number of different forms and may be retrievable. In some embodiments, a device is sized and shaped to extend from septum secundum, into the left atrium, through septum primum, and into the right atrium, such that the first and second ends cooperate to provide a compressive force to the overlapping layers of tissue. In some embodiments, the closure devices may be delivered with a catheter capable of puncturing mammalian tissue.
Description
- This Application is a Divisional of U.S. patent application Ser. No. 10/341,802, entitled Patent Foramen Ovale (PFO) Closure Method and Device, filed Jan. 14, 2003, and incorporated herein by this reference.
- The invention relates to occlusion devices and methods for the closure of physical anomalies, like septal apertures, such as patent foramen ovale and other septal and vascular defects.
- A patent foramen ovale (PFO) as shown in
FIG. 1 , is a persistent, one-way, usually flap-like opening in the wall between theright atrium 10 andleft atrium 12 of the heart. Since left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap typically stays closed. Under certain conditions, however, RA pressure can exceed LA pressure creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. In utero, the foramen ovale serves as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two over-lapping layers of tissue:septum primum 14 and septum secundum 16. However, a PFO has been shown to persist in a number of adults. - The cause of ischemic stroke remains cryptogenic (of unknown origin) in approximately 40% of cases. Especially in young patients, paradoxical embolism via a PFO is considered in the diagnosis. While there is currently no proof for a cause-effect relationship, many studies have confirmed a strong association between the presence of a PFO and the risk for paradoxical embolism or stroke. In addition, there is good evidence that patients with PFO and paradoxical embolism are at increased risk for future, recurrent cerebrovascular events.
- The presence of a PFO has no therapeutic consequence in otherwise healthy adults. In contrast, patients suffering a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another cause of ischemic stroke are considered for prophylactic medical therapy to reduce the risk of a recurrent embolic event. These patients are commonly treated with oral anticoagulants, which have the potential for adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs.
- In certain cases, such as when anticoagulation is contraindicated, surgery may be used to close the PFO. To suture a PFO closed requires attachment of septum secundum to septum primum with either an interrupted or a continuous stitch, which is the common way a surgeon shuts the PFO under direct visualization.
- Nonsurgical closure of PFOs has become possible with the advent of umbrella devices and a variety of other similar mechanical closure designs, developed initially for percutaneous closure of atrial septal defects (ASD). These devices allow patients to avoid the potential side effects often associated with anticoagulation therapies.
- Currently available designs of septal closure devices, however, present such drawbacks as technical complexity of implantation procedure, high complication rates (thrombus, fractures, conduction system disturbances, perforations, residual leaks), high septal profile, large masses of foreign material, and lack of anatomic conformability especially to the PFO flap-like anatomy, as most were originally designed to close ASD's, which are true holes. Additionally, some septal closure devices are complex to manufacture, which can result in lack of consistency in product performance.
- In one aspect, the present invention provides a method of closing two overlapping layers of tissue in a mammalian heart, e.g., a patent foramen ovale (PFO), using a closure device that applies a compressive force to at least one of the layers of tissue. The closure device may be retrievable, such that it may be removed after a period of time sufficient to allow the overlapping layers of tissue to fuse together. If necessary to sufficiently close the length of the layers of tissue, multiple closure devices may be administered. The closure devices may be delivered with a catheter capable of puncturing mammalian tissue in at least one location.
- The closure device of the present invention may take a number of different forms. For example, the closure device may have first and second ends, both of which may be capable of puncturing mammalian tissue. The device may be a structure such as a ring with a gap, a folded ring, at least one grappling hook member joined to at least one curved arm by a joinder member, opposed grappling hook members joined by a central connecting member, a grappling hook member and a central connecting member, or a closure device anchor joined to a structure of sufficient diameter to hold the device in place against the overlapping layers of tissue. In some embodiments of the present invention, the closure device is sized and shaped such that it extends from septum secundum in the left atrium, into the left atrium, through septum primum, into the right atrium, and to septum secundum in the right atrium. Some retrievable devices include elongate tethers to facilitate their removal. Each of these devices has certain advantages, and one skilled in the art will be capable of selecting the device appropriate for a given application.
- The ends of the closure device may also take a number of different forms. For example, at least one end may form a disc or a closure device anchor, such as a coil, hook, or corkscrew. These end structures help to maintain the device in place. One of the ends, for example the second end, may take the form of a knot or a structure similarly capable of holding the device in place and applying a sufficient compressive force to the overlapping layers of tissue. In some embodiments, the end structure may be adjusted to alter the compressive force applied to the overlapping layers of tissue. As previously mentioned, either or both of the first and second ends may be capable of puncturing mammalian tissue. In some embodiments, the first end of the device is a septal puncture needle.
- The closure device may be formed of any of several materials, such as flexible polymer materials, bioabsorbable materials, shape memory materials, metals, noble metals, or swellable foams. In particular embodiments, the device includes nitinol. Some of the devices are formed from a single piece of material, while others are formed from multiple pieces of material joined together.
- Some closure devices according to the present invention are intended to puncture septum primum upon insertion into the heart. For example, such a device may be inserted into the right atrium of the heart and puncture septum primum to enter the left atrium of the heart. At this point, the first end of the device may simply be deployed into the left atrium, or the first end of the device may be deployed into the left atrium and at least partially puncture septum secundum. In those embodiments where the first end of the device at least partially punctures septum secundum, the first end may be embedded in septum secundum or may completely puncture septum secundum such that the first end extends into the right atrium. The second end of the device may then be positioned against septum secundum in the right atrium, thereby providing a compressive force to the septal tissues. In other embodiments, the second end is also positioned in the left atrium while another portion of the device, such as a fold, is positioned in the right atrium, thereby compressing the septal tissues between the device.
- Alternatively, some closure devices according to the present invention are intended to be inserted between the overlapping layers of tissue, e.g. through the PFO tunnel, to enter the left atrium. In these embodiments, the first end of the device is then deployed in the left atrium and the second end of the device is deployed in the right atrium, thereby providing a compressive force to the septal tissue. As discussed above, at least one of the ends of the device may partially puncture septum secundum.
- These and other features will become readily apparent from the following detailed description wherein embodiments of the invention are shown and described by way of illustration.
-
FIG. 1 is a diagrammatic sectional view of a Patent Foramen Ovale (PFO); -
FIG. 2 is a view in side elevation of the PFO closure device with mechanical anchors of the present invention; -
FIGS. 3 a, 3 b and 3 c illustrate the steps in the deployment of the PFO closure device ofFIG. 2 ; -
FIG. 4 is a view in side elevation of a second embodiment of the PFO closure device with mechanical anchors of the present invention; -
FIGS. 5 a, 5 b and 5 c illustrate the steps in the deployment of the PFO closure device ofFIG. 4 ; -
FIG. 6 is a view in side elevation of a catheter and septal puncture needle used to pierce septum primum; -
FIG. 7 is a view in side elevation of a needle anchor for PFO closure; -
FIG. 8 is a view in side elevation of a suture and anchor used for PFO closure; -
FIG. 9 is a diagram of multiple anchor placement for PFO closure; -
FIGS. 10 a, 10 b and 10 c illustrate the steps in the deployment of a rivet and suture type of PFO closure device; -
FIGS. 11 a, 11 b, 11 c and lid illustrate the steps in the deployment of a removable PFO closure device; -
FIGS. 12 a, 12 b and 12 c illustrate the steps in the deployment of a multiple hook PFO closure device; -
FIG. 13 is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention; -
FIG. 14 is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention; and -
FIGS. 15 a, 15 b, and 15 c are an end face view from the right atrium, an end face view from the left atrium, and a side elevation view, respectively, of the deployed alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention. - Referring to
FIGS. 2 and 3 , a PFO closure device with mechanical anchors indicated generally at 18 includes opposed grapplinghook members member 24. When thePFO closure device 18 is deployed, the grapplinghook members FIGS. 2 and 3 , threecurved hooks hook member 20 and threecurved hooks hook member 22. As shown inFIG. 2 , the grapplinghooks member 24. The grappling hooks of grapplinghook members hook member 20 is situated precisely between two opposed grappling hooks of grapplinghook member 22. The angle between any two grappling hooks of grapplinghook members member 24. In this form, the PFO closure device extends longitudinally within acatheter 38. - To deploy the
PFO closure device 18, thecatheter 38 is inserted from theright atrium 10 through the PFO tunnel, i.e. between septum primum 14 andseptum secundum 16, into theleft atrium 12. As shown inFIG. 3 a, the grapplinghook member 20 is deployed into the left atrium. Next, as shown inFIG. 3b , thecatheter 38 is drawn back into the right atrium and the grapplinghooks member 24 extends at an angle through the PFO tunnel permitting septum primum and septum secundum to be drawn to the closed position and secured by the grapplinghooks FIG. 3 c, thecatheter 38 is drawn back to permit the grapplinghook member 22 to deploy, and grapplinghooks - The grappling
hook members catheter 38. The central connectingmember 24 may also be formed of bioabsorbable material, such as an absorbable suture material, so the device will ultimately leave no foreign substance in either atrium. Alternatively, the grapplinghook members hook member 20 and a central connectingmember 24 so that the device is repositionable and retrievable. When the device is made of a bioabsorbable material or is not intended to be retrievable, the ends of grapplinghooks hook members - As shown in
FIG. 3 , the closure device will conform, at least to some extent, to the septal tissue that it compresses. The extent of this conformance depends upon the material from which the device was formed: a device formed of a spring metal or shape memory material will conform to the surrounding septal tissue to a lesser extent than one formed of a flexible, bioabsorbable polymer material. -
FIG. 4 shows a second embodiment of a PFO closure device with mechanical anchors indicated generally at 40. This device, when deployed, forms a ring hook design that terminates in two opposed, pointed ends 42 and 44. The device may be straightened to pass through acatheter 38. To deploy the device as shown inFIGS. 5 a, 5 b and 5 c, the catheter is caused to pierce septum primum 14 and enter the left atrium where thepointed end 42 is deployed. Then, as shown inFIG. 5 b, the catheter is drawn back through septum primum to draw the device through septum primum and embed thepointed end 42 in the left side of septum secundum. Finally, as shown inFIG. 5 c, the catheter is withdrawn to fully deploy the PFO closure device and thepointed end 44 is embedded in the right side of septum secundum to compress septum primum and septum secundum together. As shown inFIGS. 4 and 5 , the ringPFO closure device 40, when deployed, may include a gap that is slightly smaller than the thickness of septum secundum into which it is embedded. In some embodiments, the opposed ends 42 and 44 of the deployedPFO closure device 40 contact each other or overlap. - As shown in
FIGS. 13 and 14 ,closure device 40 may take alternative forms. For example,closure devices Closure devices FIG. 5 . When deployed, the pointed ends 92 and 94 or 102 and 104 puncture the surface of septum secundum exposed in the left atrium and at least one of the folds contacts the surface of septum secundum exposed in the right atrium (FIGS. 15 a and 15 b). Septum primum and septum secundum are thus compressed between the pointed ends and at least one of the folds of the device (FIG. 15 c). - Multiple
PFO closure devices FIGS. 4, 13 , and 14, the PFO closure device may be a monolithic structure. - A PFO may also be closed with one or more sutures. As used in the art and indicated in the Figures, “suture” refers to a single connection used to hold two pieces of material or tissue together and need not be a continuous stitch. However, to suture a PFO closed has conventionally required the attachment of septum secundum to septum primum with a continuous stitch. This need for a continuous stitch can be eliminated by implanting sutures across the PFO using implantable suture anchors. As shown in
FIGS. 6 and 7 , acatheter 46 is used to puncture septum primum and then septum secundum. In the case of septum primum, the puncture creates a hole through which the catheter can pass; in the case of septum secundum, the puncture may be a depression that does not pass through septum secundum. A single puncture may be made in septum secundum as shown inFIGS. 6-8 , or, as subsequently described and shown inFIG. 9 , multiple punctures may be made. These punctures are made using a sharppointed needle tip 48. Following puncture to a desired depth, thecatheter 46 surrounding theneedle 48 is withdrawn and the needle component returns (most likely via shape memory) to its predetermined anchor-shape. - The anchors are most likely fabricated from a shape memory alloy, such as nitinol, although they could be made from a flexible, bioabsorbable polymer or a noble metal, each having their own advantage—no long term implant issues with bioabsorbable anchors and excellent radiopacity with anchors fabricated from a noble metal, such as platinum-iridium. The remainder of the suture may be formed of any suitable material, including wire, polymeric materials, and bioabsorbable materials.
- The suturing method includes using a standard septal puncture technique to locate and puncture septum primum. Following this, several approaches exist. One would be that the septal puncture needle would be withdrawn from the catheter and the suturing system then delivered through the catheter (the septal needle catheter would maintain position across septum primum during the exchange). Alternatively, a wire could be placed through the septal needle catheter to maintain position and the suture system could be delivered over the wire, or the septal puncture needle could become part of the suture system. Following delivery of the suture system, the proximal end of the suture may then be tied off so as to secure the system in place and keep the PFO closed. As described below for the rivet design suture system and shown in
FIG. 10 c, the proximal end of the suture may be formed into a knot, i.e. the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place. Other suitable structures for the proximal end of the suture include, but are not limited to, coils, spirals, and other adjustable mechanisms. This structure should apply sufficient compression to hold septum primum and septum secundum together. The structure may be adjustable, such that the level of compression may be altered as necessary. Multiple sutures may be inserted until the physician is satisfied with the PFO closure. - In
FIG. 8 , asuture 50 is delivered through the septal needle catheter following the removal of the needle. Asuture catheter 52 enters the left atrium through the septal needle catheter, is pulled back against septum secundum, setting the needle tip(s) 54 deep within it or through it, if it is thin enough. The tip could be either radiopaque, echogenic, or both, to be visible by x-ray (fluoroscopy) and/or cardiac echo. Once proper position is determined, the constricting system (a hypotube or a series of con-axial hypotubes in the embodiment where multiple needles are simultaneously delivered) is withdrawn, allowing thesuture anchor 56 to form into a pre-determined shape tissue anchor, most likely via shape memory properties. Theanchor 56 on the end of thesuture 50 has been embedded in septum secundum and expands to anchor the suture, which passes through septum primum once the suture catheter is removed. The anchor shape can be one of many different options, including but not limited to a coil, hook, corkscrew, or grappling hook. - In those cases where a true puncture through septum secundum can be made, an anchor can be placed entirely in the right atrium, leaving nothing but suture in the left atrium. These anchors may be short strips or cylindrical rods made from a metallic or polymeric material that is biostable or bioabsorbable, or a piece of swellable foam, such as Ivalon.
- In another embodiment, the septal needle catheter crosses septum secundum in multiple locations simultaneously. In this embodiment, the final result, as seen from the left atrium in an end face view of septum primum and septum secundum, would be as shown in
FIG. 9 , where a plurality of spacedanchors 58 engage septum secundum. - A rivet
design suture system 60 is shown inFIGS. 10 a, 10 b and 10 c. Here asuture 62 andanchor 64 are contained within acatheter 66, which pierces both septum secundum and septum primum. Theanchor 64, which is formed of a firm material, such as a metal disc, a small hook (such as the shape memory hooks previously described), or a piece of bio-absorbable polymer, is then deployed into the left atrium, and thesuture 62 andcatheter 66 are then pulled back as shown inFIG. 10 b to compress the two septa together. Thesuture 62 can then be knotted withknot 68, as shown inFIG. 10 c, to secure thesystem 60 in place to keep the PFO closed, i.e. the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place. Other suitable structures for the second end of the suture include, but are not limited to, coils, spirals, other adjustable mechanisms. As shown inFIG. 10 c, this structure should apply sufficient compression to hold septum primum and septum secundum together. The structure may be adjustable, such that the level of compression may be altered as necessary. Multiple rivet systems can be inserted until a physician is satisfied with the PFO closure. - The PFO closure device of the present invention may be formed in a manner to facilitate removal once septum primum and septum secundum are fused. An exemplary removable
PFO closure device 70 is deployed in the manner illustrated byFIGS. 11 a-11 d. ThePFO closure device 70 may be delivered by a delivery catheter orsheath 72 and includes a grapplinghook member 74 joined to acurved arm 76 by an enlargedtip joinder member 78. At least one of the grappling hook member and curved arm of the PFO closure device may be curved relative to the other. Anelongate tether 80 is connected to thetip joinder member 78 and extends back through thecatheter 72. Thetether 80 can be coated to minimize trauma to the veins. - To deploy the removable
PFO closure device 70 according to one embodiment of the invention, the grapplinghook member 74 is passed through septum primum 14 (FIG. 11 b), and the grappling hook, when free of the catheter, curves in a manner convex relative to the surface of septum secundum and penetrates septum secundum 16 (FIG. 11 c). Then, the grappling hook is drawn back toward the catheter by thetether 80 to apply tension to the tissue causing septum secundum to be drawn into contact with septum primum. Then thecurved arm 76 is deployed (FIG. 11 d) and curves in a manner concave relative to septum secundum so as to engage septum secundum as the catheter is drawn back. The compressive force applied by the grappling hook and the curved arm hold septum primum and septum secundum tightly together. The grapplinghook 74 andcurved arm 76 are preferably formed of shape memory material, such as nitinol, so that they respond to body temperature when deployed from thecatheter 72 to form the shape shown inFIG. 11 d. - Once the
PFO closure device 70 is in place, thecatheter 72 is withdrawn and the free end of thetether 80 is attached to a button subcutaneously and allowed to remain in place for a period of time sufficient to allow the two septa to fuse together. Then the device is pulled through septum primum and into a recovery sheath by means of thetether 80 and removed. - The
PFO closure device 70 can be deployed as shown inFIG. 11 without thetether 80 to provide a free standing device with the grapplinghook 74 andarm 76 being formed to press the twosepta joinder member 78 and draws the device through septum primum 14 and into a removal sheath. - Instead of a single opposed grappling
hook 74 andcurved arm 76, the PFO closure device can include a plurality of opposed grappling hooks and curved arms radially extending in a spaced relationship from thejoinder member 78. Such adevice 82 is shown inFIG. 12 . Here, the PFO closure device includes a plurality of grapplinghooks 84 and a plurality of opposedcurved arms 86 which are enclosed in adelivery catheter 72. Asmall hole 88 is created in septum primum 14 to permit insertion of the catheter into the left atrium and the grapplinghooks 84 are deployed as shown inFIG. 12 a. Then, the delivery catheter is drawn back to engage the hooks with both septum secundum and septum primum as shown inFIG. 12 b. Next, as shown inFIG. 12 c, the catheter is drawn away to release thecurved arms 86, which engage the two septa in opposed relationship to the grapplinghooks 84. The device may have many, e.g. eight, opposed grappling hooks and curved arms. As in the case of thePFO closure device 70, thedevice 82 may be removed by grasping thetip joinder member 78. - The
device 82 may be permanently deployed by inserting the catheter through the PFO channel between septum secundum and septum primum into the left atrium to deploy the grapplinghooks 84. Then, the catheter is withdrawn back through the PFO channel to release thecurved arms 86. - Having described embodiments of the present invention, it should be apparent that the invention is capable of other and different embodiments and may be modified in various respects, all without departing from the scope of the invention as defined by the appended claims. Accordingly, the foregoing drawings and description are to be regarded as illustrative in nature and not in a restrictive or limiting sense.
Claims (19)
1. A device for closing two overlapping layers of septum primum and septum secundum dividing a left atrium and a right atrium in a mammalian heart, said device having first and second ends, wherein said device is sized and shaped to extend from septum secundum, into the left atrium, through septum primum, and into the right atrium, said first and second ends cooperating to provide a compressive force to the overlapping layers of tissue.
2. The device of claim 1 , wherein said first end is embedded in, and does not extend through, septum secundum.
3. The device of claim 2 , wherein said first end is formed into a coil, hook, corkscrew, or other anchor.
4. The device of claim 1 , wherein said first end includes a material selected from the group consisting of bioresorbable materials, noble metals, shape memory materials, metals, polymeric materials, and swellable foams.
5. The device of claim 4 , wherein said shape memory material includes nitinol.
6. The device of claim 1 , wherein said first end includes a septal puncture needle capable of puncturing mammalian tissue.
7. The device of claim 1 , further comprising a catheter containing said device in an elongated, low-profile form, said first end being expandable to form an anchor and said second end being adjustable to alter a compressive force applied to the overlapping layers of tissue.
8. The device of claim 1 , wherein said device is sized and shaped to further extend to septum secundum in the right atrium.
9. The device of claim 8 , wherein said device includes a ring with a gap terminating in first and second opposed, pointed ends for puncturing mammalian tissue.
10. The device of claim 9 , wherein said device includes a material selected from the group consisting of flexible polymers, bioabsorbable materials, spring metals, and shape memory materials.
11. The device of claim 10 , wherein said device includes nitinol.
12. The device of claim 9 , wherein said device consists essentially of a monolithic partial ring.
13. The device of claim 9 , wherein said device includes a gap slightly smaller than the thickness of the overlapping layers of tissue to which it is connected.
14. The device of claim 9 , wherein said device includes a gap slightly smaller than the thickness of septum secundum.
15. The device of claim 9 , wherein said first and second ends overlap each other.
16. The device of claim 1 , wherein said device includes a partial ring with first and second ends and at least one fold therebetween.
17. The device of claim 16 , wherein said at least one fold cooperates with said first and second ends to apply a compressive force to said overlapping layers of tissue.
18. The device of claim 16 , wherein said device consists essentially of a monolithic partial ring.
19. The device of claim 1 , wherein said device is sized and shaped to further contact the surfaces of septum primum exposed in both the left and right atria.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/796,937 US20070265642A1 (en) | 2002-01-14 | 2007-04-30 | Patent foramen ovale (PFO) closure method and device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34733602P | 2002-01-14 | 2002-01-14 | |
US10/341,802 US7220265B2 (en) | 2002-01-14 | 2003-01-14 | Patent foramen ovale (PFO) closure method and device |
US11/796,937 US20070265642A1 (en) | 2002-01-14 | 2007-04-30 | Patent foramen ovale (PFO) closure method and device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/341,802 Division US7220265B2 (en) | 2002-01-14 | 2003-01-14 | Patent foramen ovale (PFO) closure method and device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070265642A1 true US20070265642A1 (en) | 2007-11-15 |
Family
ID=23363283
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/341,802 Expired - Fee Related US7220265B2 (en) | 2002-01-14 | 2003-01-14 | Patent foramen ovale (PFO) closure method and device |
US11/796,937 Abandoned US20070265642A1 (en) | 2002-01-14 | 2007-04-30 | Patent foramen ovale (PFO) closure method and device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/341,802 Expired - Fee Related US7220265B2 (en) | 2002-01-14 | 2003-01-14 | Patent foramen ovale (PFO) closure method and device |
Country Status (6)
Country | Link |
---|---|
US (2) | US7220265B2 (en) |
EP (1) | EP1471835A4 (en) |
JP (1) | JP2005525843A (en) |
AU (1) | AU2003210510A1 (en) |
CA (1) | CA2471871A1 (en) |
WO (1) | WO2003059152A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100234878A1 (en) * | 2009-03-16 | 2010-09-16 | Cook Incorporated | Closure device with string retractable umbrella |
US8369930B2 (en) | 2009-06-16 | 2013-02-05 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US9259290B2 (en) | 2009-06-08 | 2016-02-16 | MRI Interventions, Inc. | MRI-guided surgical systems with proximity alerts |
US9375218B2 (en) | 2006-05-03 | 2016-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US10485545B2 (en) | 2013-11-19 | 2019-11-26 | Datascope Corp. | Fastener applicator with interlock |
US20210205006A1 (en) * | 2020-01-07 | 2021-07-08 | Virender K. Sharma | Methods and Devices for Endoscopic Resection |
US11653928B2 (en) | 2018-03-28 | 2023-05-23 | Datascope Corp. | Device for atrial appendage exclusion |
Families Citing this family (146)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6949116B2 (en) | 1996-05-08 | 2005-09-27 | Carag Ag | Device for plugging an opening such as in a wall of a hollow or tubular organ including biodegradable elements |
WO1998007375A1 (en) * | 1996-08-22 | 1998-02-26 | The Trustees Of Columbia University | Endovascular flexible stapling device |
US6613059B2 (en) | 1999-03-01 | 2003-09-02 | Coalescent Surgical, Inc. | Tissue connector apparatus and methods |
US8118822B2 (en) | 1999-03-01 | 2012-02-21 | Medtronic, Inc. | Bridge clip tissue connector apparatus and methods |
US6926730B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
US6551332B1 (en) | 2000-03-31 | 2003-04-22 | Coalescent Surgical, Inc. | Multiple bias surgical fastener |
US6440152B1 (en) * | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
US6896692B2 (en) | 2000-12-14 | 2005-05-24 | Ensure Medical, Inc. | Plug with collet and apparatus and method for delivering such plugs |
US6846319B2 (en) | 2000-12-14 | 2005-01-25 | Core Medical, Inc. | Devices for sealing openings through tissue and apparatus and methods for delivering them |
US8083768B2 (en) | 2000-12-14 | 2011-12-27 | Ensure Medical, Inc. | Vascular plug having composite construction |
US6890343B2 (en) | 2000-12-14 | 2005-05-10 | Ensure Medical, Inc. | Plug with detachable guidewire element and methods for use |
US6623509B2 (en) | 2000-12-14 | 2003-09-23 | Core Medical, Inc. | Apparatus and methods for sealing vascular punctures |
US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
US7288105B2 (en) | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US20070112338A1 (en) * | 2005-11-01 | 2007-05-17 | Microfabrica Inc. | Microdevices for tissue approximation and retention, methods for using, and methods for making |
US20070198038A1 (en) * | 2001-12-03 | 2007-08-23 | Cohen Adam L | Microdevices for Tissue Approximation and Retention, Methods for Using, and Methods for Making |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
US20030130621A1 (en) * | 2002-01-04 | 2003-07-10 | Bryan Vincent E. | Spinal needle system |
WO2003082076A2 (en) | 2002-03-25 | 2003-10-09 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
US7976564B2 (en) * | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
JP2005528181A (en) | 2002-06-05 | 2005-09-22 | エヌエムティー メディカル インコーポレイテッド | Patent foramen ovale (PFO) occlusion device with radial and circumferential supports |
US8066724B2 (en) * | 2002-09-12 | 2011-11-29 | Medtronic, Inc. | Anastomosis apparatus and methods |
US20110092988A1 (en) * | 2002-10-29 | 2011-04-21 | Microfabrica Inc. | Microdevices for Tissue Approximation and Retention, Methods for Using, and Methods for Making |
US8454652B1 (en) | 2002-10-29 | 2013-06-04 | Adam L. Cohen | Releasable tissue anchoring device, methods for using, and methods for making |
CA2503666A1 (en) | 2002-12-09 | 2004-06-24 | Nmt Medical, Inc. | Septal closure devices |
US20040143294A1 (en) * | 2003-01-22 | 2004-07-22 | Cardia, Inc. | Septal stabilization device |
WO2004069055A2 (en) | 2003-02-04 | 2004-08-19 | Ev3 Sunnyvale Inc. | Patent foramen ovale closure system |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US7293562B2 (en) | 2003-03-27 | 2007-11-13 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
US6939348B2 (en) * | 2003-03-27 | 2005-09-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
WO2004087235A2 (en) | 2003-03-27 | 2004-10-14 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US8021362B2 (en) | 2003-03-27 | 2011-09-20 | Terumo Kabushiki Kaisha | Methods and apparatus for closing a layered tissue defect |
US7972330B2 (en) | 2003-03-27 | 2011-07-05 | Terumo Kabushiki Kaisha | Methods and apparatus for closing a layered tissue defect |
US7165552B2 (en) * | 2003-03-27 | 2007-01-23 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
US20040267306A1 (en) | 2003-04-11 | 2004-12-30 | Velocimed, L.L.C. | Closure devices, related delivery methods, and related methods of use |
US8372112B2 (en) | 2003-04-11 | 2013-02-12 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods, and related methods of use |
EP2191790A3 (en) * | 2003-05-19 | 2012-10-17 | SeptRx, Inc. | Tissue distention device and related methods for therapeutic intervention |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
EP1651116B1 (en) | 2003-07-14 | 2013-06-26 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US7691112B2 (en) | 2003-09-11 | 2010-04-06 | Nmt Medical, Inc. | Devices, systems, and methods for suturing tissue |
WO2005027753A1 (en) | 2003-09-19 | 2005-03-31 | St. Jude Medical, Inc. | Apparatus and methods for tissue gathering and securing |
US8394114B2 (en) | 2003-09-26 | 2013-03-12 | Medtronic, Inc. | Surgical connection apparatus and methods |
WO2005034738A2 (en) * | 2003-10-10 | 2005-04-21 | Proximare, Inc. | Patent foramen ovale (pfo) closure devices, delivery apparatus and related methods and systems |
US20050192627A1 (en) * | 2003-10-10 | 2005-09-01 | Whisenant Brian K. | Patent foramen ovale closure devices, delivery apparatus and related methods and systems |
US8852229B2 (en) | 2003-10-17 | 2014-10-07 | Cordis Corporation | Locator and closure device and method of use |
US7361183B2 (en) | 2003-10-17 | 2008-04-22 | Ensure Medical, Inc. | Locator and delivery device and method of use |
ES2293357T3 (en) * | 2003-10-24 | 2008-03-16 | Ev3 Endovascular, Inc. | CLOSURE SYSTEM OF A PERMEABLE OVAL FORM. |
US7666203B2 (en) * | 2003-11-06 | 2010-02-23 | Nmt Medical, Inc. | Transseptal puncture apparatus |
US8292910B2 (en) | 2003-11-06 | 2012-10-23 | Pressure Products Medical Supplies, Inc. | Transseptal puncture apparatus |
US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
US7879047B2 (en) * | 2003-12-10 | 2011-02-01 | Medtronic, Inc. | Surgical connection apparatus and methods |
EP1715792A2 (en) | 2004-01-30 | 2006-11-02 | NMT Medical, Inc. | Welding systems for closure of cardiac openings |
US7871419B2 (en) | 2004-03-03 | 2011-01-18 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
US9713465B1 (en) * | 2004-04-19 | 2017-07-25 | Granit Medical Innovation Llc | Surgical closure device and associated method |
US8257389B2 (en) | 2004-05-07 | 2012-09-04 | W.L. Gore & Associates, Inc. | Catching mechanisms for tubular septal occluder |
US7367975B2 (en) | 2004-06-21 | 2008-05-06 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
US7722629B2 (en) * | 2004-10-29 | 2010-05-25 | Jeffrey W. Chambers, M.D. | System and method for catheter-based septal defect repair |
US20060106420A1 (en) * | 2004-11-12 | 2006-05-18 | Medtronic Vascular, Inc. | Patch for treating a septal defect |
US8920434B2 (en) | 2005-03-02 | 2014-12-30 | St. Jude Medical, Cardiology Division, Inc. | Remote body tissue engaging methods and apparatus |
US20060241687A1 (en) * | 2005-03-16 | 2006-10-26 | Glaser Erik N | Septal occluder with pivot arms and articulating joints |
US20060217760A1 (en) * | 2005-03-17 | 2006-09-28 | Widomski David R | Multi-strand septal occluder |
US8372113B2 (en) * | 2005-03-24 | 2013-02-12 | W.L. Gore & Associates, Inc. | Curved arm intracardiac occluder |
US7321798B2 (en) * | 2005-03-31 | 2008-01-22 | Medtronic, Inc. | Trans-septal/trans-myocardial ventricular pacing lead |
AU2006235506B2 (en) | 2005-04-11 | 2011-06-30 | Terumo Kabushiki Kaisha | Methods and apparatus to achieve a closure of a layered tissue defect |
US8088144B2 (en) | 2005-05-04 | 2012-01-03 | Ensure Medical, Inc. | Locator and closure device and method of use |
US8926654B2 (en) | 2005-05-04 | 2015-01-06 | Cordis Corporation | Locator and closure device and method of use |
EP2135560B1 (en) | 2005-06-02 | 2011-08-10 | Cordis Corporation | Medical device for deploying a mechanical closure devcie |
US20070005079A1 (en) * | 2005-06-30 | 2007-01-04 | David Zarbatany | System, apparatus, and method for repairing septal defects |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
CN101257852B (en) | 2005-07-07 | 2011-08-10 | 科迪斯公司 | Patent foramen oval closure device with steerable delivery system |
US7766906B2 (en) * | 2005-08-19 | 2010-08-03 | Boston Scientific Scimed, Inc. | Occlusion apparatus |
US8062309B2 (en) * | 2005-08-19 | 2011-11-22 | Boston Scientific Scimed, Inc. | Defect occlusion apparatus, system, and method |
US7824397B2 (en) | 2005-08-19 | 2010-11-02 | Boston Scientific Scimed, Inc. | Occlusion apparatus |
US7837619B2 (en) * | 2005-08-19 | 2010-11-23 | Boston Scientific Scimed, Inc. | Transeptal apparatus, system, and method |
US7998095B2 (en) * | 2005-08-19 | 2011-08-16 | Boston Scientific Scimed, Inc. | Occlusion device |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
AU2006287211B2 (en) | 2005-09-01 | 2012-09-27 | Cardinal Health 529, Llc | Patent foramen ovale closure method |
US9259267B2 (en) | 2005-09-06 | 2016-02-16 | W.L. Gore & Associates, Inc. | Devices and methods for treating cardiac tissue |
WO2007030433A2 (en) | 2005-09-06 | 2007-03-15 | Nmt Medical, Inc. | Removable intracardiac rf device |
US10143456B2 (en) * | 2005-10-07 | 2018-12-04 | Alex Javois | Left atrial appendage occlusion device |
US20070093805A1 (en) * | 2005-10-17 | 2007-04-26 | Coaptus Medical Corporation | Systems and methods for securing cardiovascular tissue, including via asymmetric electrodes |
US20070112385A1 (en) | 2005-11-15 | 2007-05-17 | Conlon Sean P | Expandable suture anchor |
EP1962695A1 (en) | 2005-12-22 | 2008-09-03 | NMT Medical, Inc. | Catch members for occluder devices |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
US20070270905A1 (en) * | 2006-05-18 | 2007-11-22 | Cook Incorporated | Patent foramen ovale closure device and method |
CA2653396C (en) * | 2006-06-09 | 2015-02-17 | Cordis Corporation | Single disc occlusionary patent foramen ovale closure device |
US20080039743A1 (en) * | 2006-08-09 | 2008-02-14 | Coherex Medical, Inc. | Methods for determining characteristics of an internal tissue opening |
US9138208B2 (en) | 2006-08-09 | 2015-09-22 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
US8529597B2 (en) * | 2006-08-09 | 2013-09-10 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
US8075576B2 (en) * | 2006-08-24 | 2011-12-13 | Boston Scientific Scimed, Inc. | Closure device, system, and method |
WO2008036384A2 (en) * | 2006-09-21 | 2008-03-27 | Synecor, Llc | Stomach wall closure devices |
US8029532B2 (en) * | 2006-10-11 | 2011-10-04 | Cook Medical Technologies Llc | Closure device with biomaterial patches |
DE602007009915D1 (en) * | 2006-11-20 | 2010-12-02 | Septrx Inc | Device for preventing unwanted flow of emboli from the veins into the arteries |
US8784439B1 (en) * | 2006-11-28 | 2014-07-22 | Stephen V. Ward | Percutaneous medical procedures and devices for closing vessels using mechanical closures |
WO2008094706A2 (en) * | 2007-02-01 | 2008-08-07 | Cook Incorporated | Closure device and method of closing a bodily opening |
US8617205B2 (en) | 2007-02-01 | 2013-12-31 | Cook Medical Technologies Llc | Closure device |
WO2008124603A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Septal closure device with centering mechanism |
US9138562B2 (en) | 2007-04-18 | 2015-09-22 | W.L. Gore & Associates, Inc. | Flexible catheter system |
US8734483B2 (en) * | 2007-08-27 | 2014-05-27 | Cook Medical Technologies Llc | Spider PFO closure device |
US8308752B2 (en) * | 2007-08-27 | 2012-11-13 | Cook Medical Technologies Llc | Barrel occlusion device |
US8025495B2 (en) * | 2007-08-27 | 2011-09-27 | Cook Medical Technologies Llc | Apparatus and method for making a spider occlusion device |
US20090062838A1 (en) * | 2007-08-27 | 2009-03-05 | Cook Incorporated | Spider device with occlusive barrier |
EP2184019B1 (en) * | 2007-08-28 | 2015-12-09 | Terumo Kabushiki Kaisha | Device for opening/closing biological tissue |
WO2009046441A1 (en) * | 2007-10-05 | 2009-04-09 | Coaptus Medical Corporation | Systems and methods for transeptal cardiac procedures |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
US8177836B2 (en) * | 2008-03-10 | 2012-05-15 | Medtronic, Inc. | Apparatus and methods for minimally invasive valve repair |
DE102008013860A1 (en) | 2008-03-12 | 2009-09-24 | Siemens Aktiengesellschaft | Catheter device for treatment of septum of heart, has coupling device arranged at proximal end in proximity of catheter tip to transport and position occluder, where sensor is provided in area of catheter tip for imaging |
FR2930137B1 (en) | 2008-04-18 | 2010-04-23 | Corevalve Inc | TREATMENT EQUIPMENT FOR A CARDIAC VALVE, IN PARTICULAR A MITRAL VALVE. |
JP5421987B2 (en) * | 2008-04-23 | 2014-02-19 | クック メディカル テクノロジーズ エルエルシー | Mounting device |
US20090292309A1 (en) * | 2008-05-20 | 2009-11-26 | Michael Maschke | System and workflow for diagnosing and treating septum defects |
US8333788B2 (en) * | 2008-10-09 | 2012-12-18 | Covidien Lp | Knotted suture end effector |
US8323316B2 (en) * | 2008-10-09 | 2012-12-04 | Covidien Lp | Knotted suture end effector |
US20100241140A1 (en) * | 2009-03-18 | 2010-09-23 | Medtronic, Inc. | Medical Clip with Bridge, System and Method of Using Same |
US8668704B2 (en) * | 2009-04-24 | 2014-03-11 | Medtronic, Inc. | Medical clip with tines, system and method of using same |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
WO2011056981A2 (en) | 2009-11-04 | 2011-05-12 | Nitinol Devices And Components, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
EP2525723B1 (en) | 2010-01-20 | 2017-09-20 | Micro Interventional Devices, Inc. | Tissue repair implant and delivery device |
US9980708B2 (en) | 2010-01-20 | 2018-05-29 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10959840B2 (en) | 2010-01-20 | 2021-03-30 | Micro Interventional Devices, Inc. | Systems and methods for affixing a prosthesis to tissue |
US10058314B2 (en) | 2010-01-20 | 2018-08-28 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10743854B2 (en) | 2010-01-20 | 2020-08-18 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US9072603B2 (en) * | 2010-02-24 | 2015-07-07 | Medtronic Ventor Technologies, Ltd. | Mitral prosthesis and methods for implantation |
US20110218191A1 (en) * | 2010-03-03 | 2011-09-08 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long term-treatment of kidney disorders in cats |
US8357195B2 (en) | 2010-04-15 | 2013-01-22 | Medtronic, Inc. | Catheter based annuloplasty system and method |
US9795482B2 (en) | 2010-04-27 | 2017-10-24 | Medtronic, Inc. | Prosthetic heart valve devices and methods of valve repair |
US9526483B2 (en) * | 2010-07-15 | 2016-12-27 | Medtronic Vascular Galway | Apical closure system |
WO2012047308A1 (en) | 2010-10-08 | 2012-04-12 | Nitinol Devices And Components, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
EP2627265B8 (en) | 2010-10-15 | 2019-02-20 | Cook Medical Technologies LLC | Occlusion device for blocking fluid flow through bodily passages |
JP2014508571A (en) * | 2011-01-11 | 2014-04-10 | アムセル・メディカル・コーポレーション | Method and apparatus for treating varicose veins |
US8454656B2 (en) | 2011-03-01 | 2013-06-04 | Medtronic Ventor Technologies Ltd. | Self-suturing anchors |
US9445898B2 (en) | 2011-03-01 | 2016-09-20 | Medtronic Ventor Technologies Ltd. | Mitral valve repair |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
AU2014214700B2 (en) | 2013-02-11 | 2018-01-18 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US10993807B2 (en) | 2017-11-16 | 2021-05-04 | Medtronic Vascular, Inc. | Systems and methods for percutaneously supporting and manipulating a septal wall |
CN109247965B (en) * | 2018-10-10 | 2021-11-26 | 先健科技(深圳)有限公司 | Suturing device |
Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US3875648A (en) * | 1973-04-04 | 1975-04-08 | Dennison Mfg Co | Fastener attachment apparatus and method |
US4006747A (en) * | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4007743A (en) * | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US4149327A (en) * | 1976-07-21 | 1979-04-17 | Jura Elektroapparate-Fabriken L. Henzirohs A.G. | Steam iron |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4738666A (en) * | 1985-06-11 | 1988-04-19 | Genus Catheter Technologies, Inc. | Variable diameter catheter |
US4802478A (en) * | 1982-03-04 | 1989-02-07 | Minnesota Mining And Manufacturing Company | Medical staple and removal method |
US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US4915107A (en) * | 1988-03-09 | 1990-04-10 | Harley International Medical Ltd. | Automatic instrument for purse-string sutures for surgical use |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US5078736A (en) * | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5106913A (en) * | 1986-07-16 | 1992-04-21 | Sumitomo Chemical Company, Limited | Rubber composition |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5176659A (en) * | 1991-02-28 | 1993-01-05 | Mario Mancini | Expandable intravenous catheter and method of using |
US5192301A (en) * | 1989-01-17 | 1993-03-09 | Nippon Zeon Co., Ltd. | Closing plug of a defect for medical use and a closing plug device utilizing it |
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5284488A (en) * | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5304184A (en) * | 1992-10-19 | 1994-04-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5486193A (en) * | 1992-01-22 | 1996-01-23 | C. R. Bard, Inc. | System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder |
US5507811A (en) * | 1993-11-26 | 1996-04-16 | Nissho Corporation | Prosthetic device for atrial septal defect repair |
US5601571A (en) * | 1994-05-17 | 1997-02-11 | Moss; Gerald | Surgical fastener implantation device |
US5603703A (en) * | 1995-04-28 | 1997-02-18 | Medtronic, Inc. | Selectively aspirating stylet |
US5618311A (en) * | 1994-09-28 | 1997-04-08 | Gryskiewicz; Joseph M. | Surgical subcuticular fastener system |
US5620461A (en) * | 1989-05-29 | 1997-04-15 | Muijs Van De Moer; Wouter M. | Sealing device |
US5649977A (en) * | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
US5709707A (en) * | 1995-10-30 | 1998-01-20 | Children's Medical Center Corporation | Self-centering umbrella-type septal closure device |
US5713864A (en) * | 1995-04-11 | 1998-02-03 | Sims Level 1, Inc. | Integral conductive polymer resistance heated tubing |
US5717259A (en) * | 1996-01-11 | 1998-02-10 | Schexnayder; J. Rodney | Electromagnetic machine |
US5720754A (en) * | 1989-08-16 | 1998-02-24 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5741297A (en) * | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5865791A (en) * | 1995-06-07 | 1999-02-02 | E.P. Technologies Inc. | Atrial appendage stasis reduction procedure and devices |
US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US5893856A (en) * | 1996-06-12 | 1999-04-13 | Mitek Surgical Products, Inc. | Apparatus and method for binding a first layer of material to a second layer of material |
US6010517A (en) * | 1996-04-10 | 2000-01-04 | Baccaro; Jorge Alberto | Device for occluding abnormal vessel communications |
US6019753A (en) * | 1997-12-02 | 2000-02-01 | Smiths Industries Public Limited Company | Catheter assemblies and inner cannulae |
US6024756A (en) * | 1996-03-22 | 2000-02-15 | Scimed Life Systems, Inc. | Method of reversibly closing a septal defect |
WO2000007506A2 (en) * | 1998-08-03 | 2000-02-17 | Anson Medical Ltd. | Devices and methods for the repair of arteries |
US6027519A (en) * | 1997-12-15 | 2000-02-22 | Stanford; Ulf Harry | Catheter with expandable multiband segment |
US6030007A (en) * | 1997-07-07 | 2000-02-29 | Hughes Electronics Corporation | Continually adjustable nonreturn knot |
US6168588B1 (en) * | 1995-12-12 | 2001-01-02 | Medi-Dyne Inc. | Overlapping welds for catheter constructions |
US6171329B1 (en) * | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6174322B1 (en) * | 1997-08-08 | 2001-01-16 | Cardia, Inc. | Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6183443B1 (en) * | 1992-10-15 | 2001-02-06 | Scimed Life Systems, Inc. | Expandable introducer sheath |
US6187039B1 (en) * | 1996-12-10 | 2001-02-13 | Purdue Research Foundation | Tubular submucosal graft constructs |
US6190353B1 (en) * | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
US6190357B1 (en) * | 1998-04-21 | 2001-02-20 | Cardiothoracic Systems, Inc. | Expandable cannula for performing cardiopulmonary bypass and method for using same |
US6199262B1 (en) * | 1997-08-20 | 2001-03-13 | Medtronic, Inc. | Method of making a guiding catheter |
US6206907B1 (en) * | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6206895B1 (en) * | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6214029B1 (en) * | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6217590B1 (en) * | 1999-01-22 | 2001-04-17 | Scion International, Inc. | Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor |
US6221092B1 (en) * | 1998-03-30 | 2001-04-24 | Nissho Corporation | Closure device for transcatheter operations and catheter assembly therefor |
US6334872B1 (en) * | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
US20020010481A1 (en) * | 1999-12-23 | 2002-01-24 | Swaminathan Jayaraman | Occlusive coil manufacture and delivery |
US6342064B1 (en) * | 1998-12-22 | 2002-01-29 | Nipro Corporation | Closure device for transcatheter operation and catheter assembly therefor |
US6344048B1 (en) * | 1997-07-10 | 2002-02-05 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6344049B1 (en) * | 1999-08-17 | 2002-02-05 | Scion Cardio-Vascular, Inc. | Filter for embolic material mounted on expandable frame and associated deployment system |
US6346074B1 (en) * | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
US20020019648A1 (en) * | 2000-04-19 | 2002-02-14 | Dan Akerfeldt | Intra-arterial occluder |
US6348041B1 (en) * | 1999-03-29 | 2002-02-19 | Cook Incorporated | Guidewire |
US20020022860A1 (en) * | 2000-08-18 | 2002-02-21 | Borillo Thomas E. | Expandable implant devices for filtering blood flow from atrial appendages |
US20020022859A1 (en) * | 1999-03-12 | 2002-02-21 | Michael Hogendijk | Catheter having radially expandable main body |
US20020026208A1 (en) * | 2000-01-05 | 2002-02-28 | Medical Technology Group, Inc. | Apparatus and methods for delivering a closure device |
US6352552B1 (en) * | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
US20020029048A1 (en) * | 2000-09-01 | 2002-03-07 | Arnold Miller | Endovascular fastener and grafting apparatus and method |
US6355052B1 (en) * | 1996-02-09 | 2002-03-12 | Pfm Produkte Fur Die Medizin Aktiengesellschaft | Device for closure of body defect openings |
US6356782B1 (en) * | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US20020032462A1 (en) * | 1998-06-10 | 2002-03-14 | Russell A. Houser | Thermal securing anastomosis systems |
US20020032459A1 (en) * | 1990-06-20 | 2002-03-14 | Danforth Biomedical, Inc. | Radially-expandable tubular elements for use in the construction of medical devices |
US6358238B1 (en) * | 1999-09-02 | 2002-03-19 | Scimed Life Systems, Inc. | Expandable micro-catheter |
US20020034259A1 (en) * | 2000-09-21 | 2002-03-21 | Katsuyuki Tada | Transmitter for automatically changing transmission data type within specified band |
US20020035374A1 (en) * | 2000-09-21 | 2002-03-21 | Borillo Thomas E. | Apparatus for implanting devices in atrial appendages |
US20030004533A1 (en) * | 2001-05-04 | 2003-01-02 | Concentric Medical | Bioactive polymer vaso-occlusive device |
US6508828B1 (en) * | 2000-11-03 | 2003-01-21 | Radi Medical Systems Ab | Sealing device and wound closure device |
US20030023266A1 (en) * | 2001-07-19 | 2003-01-30 | Borillo Thomas E. | Individually customized atrial appendage implant device |
US6514515B1 (en) * | 1999-03-04 | 2003-02-04 | Tepha, Inc. | Bioabsorbable, biocompatible polymers for tissue engineering |
US20030028213A1 (en) * | 2001-08-01 | 2003-02-06 | Microvena Corporation | Tissue opening occluder |
US20030045893A1 (en) * | 2001-09-06 | 2003-03-06 | Integrated Vascular Systems, Inc. | Clip apparatus for closing septal defects and methods of use |
US20030050665A1 (en) * | 2001-09-07 | 2003-03-13 | Integrated Vascular Systems, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20030055455A1 (en) * | 2001-09-20 | 2003-03-20 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
US20030059640A1 (en) * | 1999-11-19 | 2003-03-27 | Denes Marton | High strength vacuum deposited nitinol alloy films and method of making same |
US20030057156A1 (en) * | 2001-03-08 | 2003-03-27 | Dean Peterson | Atrial filter implants |
US6689589B2 (en) * | 1997-09-19 | 2004-02-10 | Metabolix, Inc. | Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
US20040044361A1 (en) * | 1998-11-06 | 2004-03-04 | Frazier Andrew G.C. | Detachable atrial appendage occlusion balloon |
US6712804B2 (en) * | 1999-09-20 | 2004-03-30 | Ev3 Sunnyvale, Inc. | Method of closing an opening in a wall of the heart |
US6712836B1 (en) * | 1999-05-13 | 2004-03-30 | St. Jude Medical Atg, Inc. | Apparatus and methods for closing septal defects and occluding blood flow |
US6838493B2 (en) * | 1999-03-25 | 2005-01-04 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
US20050025809A1 (en) * | 2003-07-08 | 2005-02-03 | Tepha, Inc. | Poly-4-hydroxybutyrate matrices for sustained drug delivery |
US20050043759A1 (en) * | 2003-07-14 | 2005-02-24 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US6867248B1 (en) * | 1997-05-12 | 2005-03-15 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
US6867249B2 (en) * | 2000-08-18 | 2005-03-15 | Kin Man Amazon Lee | Lightweight and porous construction materials containing rubber |
US20070010851A1 (en) * | 2003-07-14 | 2007-01-11 | Chanduszko Andrzej J | Tubular patent foramen ovale (PFO) closure device with catch system |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4696300A (en) | 1985-04-11 | 1987-09-29 | Dennison Manufacturing Company | Fastener for joining materials |
US4710192A (en) | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US5478353A (en) | 1987-05-14 | 1995-12-26 | Yoon; Inbae | Suture tie device system and method for suturing anatomical tissue proximate an opening |
US4836204A (en) * | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US4956178A (en) | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
DE69102515T2 (en) | 1990-04-02 | 1994-10-20 | Kanji Inoue | DEVICE FOR CLOSING A SHUTTER OPENING BY MEANS OF A NON-OPERATIONAL METHOD. |
US5021059A (en) * | 1990-05-07 | 1991-06-04 | Kensey Nash Corporation | Plug device with pulley for sealing punctures in tissue and methods of use |
US5037433A (en) | 1990-05-17 | 1991-08-06 | Wilk Peter J | Endoscopic suturing device and related method and suture |
US5041129A (en) | 1990-07-02 | 1991-08-20 | Acufex Microsurgical, Inc. | Slotted suture anchor and method of anchoring a suture |
US5257637A (en) | 1991-03-22 | 1993-11-02 | El Gazayerli Mohamed M | Method for suture knot placement and tying |
EP0545091B1 (en) | 1991-11-05 | 1999-07-07 | The Children's Medical Center Corporation | Occluder for repair of cardiac and vascular defects |
CA2082090C (en) * | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
US5222974A (en) * | 1991-11-08 | 1993-06-29 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
DE69324239T2 (en) | 1992-01-21 | 1999-11-04 | Univ Minnesota | SEPTUAL DAMAGE CLOSURE DEVICE |
US5411481A (en) * | 1992-04-08 | 1995-05-02 | American Cyanamid Co. | Surgical purse string suturing instrument and method |
US5236440A (en) | 1992-04-14 | 1993-08-17 | American Cyanamid Company | Surgical fastener |
US5540712A (en) * | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5354308A (en) | 1992-05-01 | 1994-10-11 | Beth Israel Hospital Association | Metal wire stent |
DE4215449C1 (en) * | 1992-05-11 | 1993-09-02 | Ethicon Gmbh & Co Kg, 2000 Norderstedt, De | |
US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US5417699A (en) * | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5312435A (en) * | 1993-05-17 | 1994-05-17 | Kensey Nash Corporation | Fail predictable, reinforced anchor for hemostatic puncture closure |
US5480424A (en) * | 1993-11-01 | 1996-01-02 | Cox; James L. | Heart valve replacement using flexible tubes |
US5683411A (en) | 1994-04-06 | 1997-11-04 | William Cook Europe A/S | Medical article for implantation into the vascular system of a patient |
US6475232B1 (en) * | 1996-12-10 | 2002-11-05 | Purdue Research Foundation | Stent with reduced thrombogenicity |
DE69534640T2 (en) | 1994-04-29 | 2006-08-10 | Scimed Life Systems, Inc., Maple Grove | Stent with collagen |
US5433727A (en) * | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
US5577299A (en) | 1994-08-26 | 1996-11-26 | Thompson; Carl W. | Quick-release mechanical knot apparatus |
US5702421A (en) | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
US5634936A (en) * | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5711969A (en) | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
US5755791A (en) | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
AU3186897A (en) * | 1996-05-08 | 1997-11-26 | Salviac Limited | An occluder device |
US5800516A (en) | 1996-08-08 | 1998-09-01 | Cordis Corporation | Deployable and retrievable shape memory stent/tube and method |
US5810884A (en) | 1996-09-09 | 1998-09-22 | Beth Israel Deaconess Medical Center | Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject |
JP4676580B2 (en) | 1996-11-05 | 2011-04-27 | パーデュー・リサーチ・ファウンデーション | Myocardial graft composition |
WO1998025549A1 (en) | 1996-12-10 | 1998-06-18 | Purdue Research Foundation | Artificial vascular valves |
US5776162A (en) * | 1997-01-03 | 1998-07-07 | Nitinol Medical Technologies, Inc. | Vessel implantable shape memory appliance with superelastic hinged joint |
JP3134287B2 (en) * | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Catheter assembly for endocardial suture surgery |
JP3134288B2 (en) * | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Endocardial suture surgery tool |
US5993844A (en) | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
US5902319A (en) * | 1997-09-25 | 1999-05-11 | Daley; Robert J. | Bioabsorbable staples |
US6106913A (en) | 1997-10-10 | 2000-08-22 | Quantum Group, Inc | Fibrous structures containing nanofibrils and other textile fibers |
US5989268A (en) | 1997-10-28 | 1999-11-23 | Boston Scientific Corporation | Endoscopic hemostatic clipping device |
US5976174A (en) | 1997-12-15 | 1999-11-02 | Ruiz; Carlos E. | Medical hole closure device and methods of use |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
US5993475A (en) | 1998-04-22 | 1999-11-30 | Bristol-Myers Squibb Co. | Tissue repair device |
US6113609A (en) | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
US6328822B1 (en) * | 1998-06-26 | 2001-12-11 | Kiyohito Ishida | Functionally graded alloy, use thereof and method for producing same |
US6165183A (en) | 1998-07-15 | 2000-12-26 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US5919200A (en) * | 1998-10-09 | 1999-07-06 | Hearten Medical, Inc. | Balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US6228097B1 (en) * | 1999-01-22 | 2001-05-08 | Scion International, Inc. | Surgical instrument for clipping and cutting blood vessels and organic structures |
US6379342B1 (en) * | 1999-04-02 | 2002-04-30 | Scion International, Inc. | Ampoule for dispensing medication and method of use |
JP2000300571A (en) * | 1999-04-19 | 2000-10-31 | Nissho Corp | Closure plug for transcatheter operation |
US6379368B1 (en) * | 1999-05-13 | 2002-04-30 | Cardia, Inc. | Occlusion device with non-thrombogenic properties |
US6165204A (en) | 1999-06-11 | 2000-12-26 | Scion International, Inc. | Shaped suture clip, appliance and method therefor |
US6245080B1 (en) * | 1999-07-13 | 2001-06-12 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US7892246B2 (en) * | 1999-07-28 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting conduits and closing openings in tissue |
EP1211983B1 (en) * | 1999-09-13 | 2007-03-07 | Rex Medical, LP | Vascular closure |
US6626930B1 (en) * | 1999-10-21 | 2003-09-30 | Edwards Lifesciences Corporation | Minimally invasive mitral valve repair method and apparatus |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6387104B1 (en) * | 1999-11-12 | 2002-05-14 | Scimed Life Systems, Inc. | Method and apparatus for endoscopic repair of the lower esophageal sphincter |
US6551344B2 (en) * | 2000-04-26 | 2003-04-22 | Ev3 Inc. | Septal defect occluder |
US6334864B1 (en) * | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
US6364853B1 (en) * | 2000-09-11 | 2002-04-02 | Scion International, Inc. | Irrigation and suction valve and method therefor |
JP2004508884A (en) * | 2000-09-25 | 2004-03-25 | コヒージョン テクノロジーズ, インコーポレイテッド | Resorbable anastomotic stent and plug |
US6375625B1 (en) * | 2000-10-18 | 2002-04-23 | Scion Valley, Inc. | In-line specimen trap and method therefor |
US6746404B2 (en) * | 2000-12-18 | 2004-06-08 | Biosense, Inc. | Method for anchoring a medical device between tissue |
US6537300B2 (en) * | 2001-05-30 | 2003-03-25 | Scimed Life Systems, Inc. | Implantable obstruction device for septal defects |
-
2003
- 2003-01-14 US US10/341,802 patent/US7220265B2/en not_active Expired - Fee Related
- 2003-01-14 CA CA002471871A patent/CA2471871A1/en not_active Abandoned
- 2003-01-14 AU AU2003210510A patent/AU2003210510A1/en not_active Abandoned
- 2003-01-14 JP JP2003559323A patent/JP2005525843A/en active Pending
- 2003-01-14 EP EP03729663A patent/EP1471835A4/en not_active Withdrawn
- 2003-01-14 WO PCT/US2003/001050 patent/WO2003059152A2/en active Application Filing
-
2007
- 2007-04-30 US US11/796,937 patent/US20070265642A1/en not_active Abandoned
Patent Citations (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US3875648A (en) * | 1973-04-04 | 1975-04-08 | Dennison Mfg Co | Fastener attachment apparatus and method |
US4006747A (en) * | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4007743A (en) * | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US4149327A (en) * | 1976-07-21 | 1979-04-17 | Jura Elektroapparate-Fabriken L. Henzirohs A.G. | Steam iron |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4802478A (en) * | 1982-03-04 | 1989-02-07 | Minnesota Mining And Manufacturing Company | Medical staple and removal method |
US4738666A (en) * | 1985-06-11 | 1988-04-19 | Genus Catheter Technologies, Inc. | Variable diameter catheter |
US5106913A (en) * | 1986-07-16 | 1992-04-21 | Sumitomo Chemical Company, Limited | Rubber composition |
US4915107A (en) * | 1988-03-09 | 1990-04-10 | Harley International Medical Ltd. | Automatic instrument for purse-string sutures for surgical use |
US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US5192301A (en) * | 1989-01-17 | 1993-03-09 | Nippon Zeon Co., Ltd. | Closing plug of a defect for medical use and a closing plug device utilizing it |
US5620461A (en) * | 1989-05-29 | 1997-04-15 | Muijs Van De Moer; Wouter M. | Sealing device |
US5720754A (en) * | 1989-08-16 | 1998-02-24 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5078736A (en) * | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US20020032459A1 (en) * | 1990-06-20 | 2002-03-14 | Danforth Biomedical, Inc. | Radially-expandable tubular elements for use in the construction of medical devices |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5176659A (en) * | 1991-02-28 | 1993-01-05 | Mario Mancini | Expandable intravenous catheter and method of using |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5486193A (en) * | 1992-01-22 | 1996-01-23 | C. R. Bard, Inc. | System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder |
US6183443B1 (en) * | 1992-10-15 | 2001-02-06 | Scimed Life Systems, Inc. | Expandable introducer sheath |
US5304184A (en) * | 1992-10-19 | 1994-04-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5284488A (en) * | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US6346074B1 (en) * | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
US5507811A (en) * | 1993-11-26 | 1996-04-16 | Nissho Corporation | Prosthetic device for atrial septal defect repair |
US6334872B1 (en) * | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
US5601571A (en) * | 1994-05-17 | 1997-02-11 | Moss; Gerald | Surgical fastener implantation device |
US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5649977A (en) * | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
US5618311A (en) * | 1994-09-28 | 1997-04-08 | Gryskiewicz; Joseph M. | Surgical subcuticular fastener system |
US6171329B1 (en) * | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5713864A (en) * | 1995-04-11 | 1998-02-03 | Sims Level 1, Inc. | Integral conductive polymer resistance heated tubing |
US5603703A (en) * | 1995-04-28 | 1997-02-18 | Medtronic, Inc. | Selectively aspirating stylet |
US5865791A (en) * | 1995-06-07 | 1999-02-02 | E.P. Technologies Inc. | Atrial appendage stasis reduction procedure and devices |
US6190353B1 (en) * | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
US5709707A (en) * | 1995-10-30 | 1998-01-20 | Children's Medical Center Corporation | Self-centering umbrella-type septal closure device |
US6168588B1 (en) * | 1995-12-12 | 2001-01-02 | Medi-Dyne Inc. | Overlapping welds for catheter constructions |
US5717259A (en) * | 1996-01-11 | 1998-02-10 | Schexnayder; J. Rodney | Electromagnetic machine |
US6355052B1 (en) * | 1996-02-09 | 2002-03-12 | Pfm Produkte Fur Die Medizin Aktiengesellschaft | Device for closure of body defect openings |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US6024756A (en) * | 1996-03-22 | 2000-02-15 | Scimed Life Systems, Inc. | Method of reversibly closing a septal defect |
US6010517A (en) * | 1996-04-10 | 2000-01-04 | Baccaro; Jorge Alberto | Device for occluding abnormal vessel communications |
US5893856A (en) * | 1996-06-12 | 1999-04-13 | Mitek Surgical Products, Inc. | Apparatus and method for binding a first layer of material to a second layer of material |
US5741297A (en) * | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US6187039B1 (en) * | 1996-12-10 | 2001-02-13 | Purdue Research Foundation | Tubular submucosal graft constructs |
US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US6867248B1 (en) * | 1997-05-12 | 2005-03-15 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
US6030007A (en) * | 1997-07-07 | 2000-02-29 | Hughes Electronics Corporation | Continually adjustable nonreturn knot |
US6344048B1 (en) * | 1997-07-10 | 2002-02-05 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6174322B1 (en) * | 1997-08-08 | 2001-01-16 | Cardia, Inc. | Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum |
US6199262B1 (en) * | 1997-08-20 | 2001-03-13 | Medtronic, Inc. | Method of making a guiding catheter |
US6689589B2 (en) * | 1997-09-19 | 2004-02-10 | Metabolix, Inc. | Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
US6019753A (en) * | 1997-12-02 | 2000-02-01 | Smiths Industries Public Limited Company | Catheter assemblies and inner cannulae |
US6027519A (en) * | 1997-12-15 | 2000-02-22 | Stanford; Ulf Harry | Catheter with expandable multiband segment |
US6221092B1 (en) * | 1998-03-30 | 2001-04-24 | Nissho Corporation | Closure device for transcatheter operations and catheter assembly therefor |
US6190357B1 (en) * | 1998-04-21 | 2001-02-20 | Cardiothoracic Systems, Inc. | Expandable cannula for performing cardiopulmonary bypass and method for using same |
US20020032462A1 (en) * | 1998-06-10 | 2002-03-14 | Russell A. Houser | Thermal securing anastomosis systems |
WO2000007506A2 (en) * | 1998-08-03 | 2000-02-17 | Anson Medical Ltd. | Devices and methods for the repair of arteries |
US20040044361A1 (en) * | 1998-11-06 | 2004-03-04 | Frazier Andrew G.C. | Detachable atrial appendage occlusion balloon |
US6342064B1 (en) * | 1998-12-22 | 2002-01-29 | Nipro Corporation | Closure device for transcatheter operation and catheter assembly therefor |
US6356782B1 (en) * | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6217590B1 (en) * | 1999-01-22 | 2001-04-17 | Scion International, Inc. | Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor |
US6514515B1 (en) * | 1999-03-04 | 2003-02-04 | Tepha, Inc. | Bioabsorbable, biocompatible polymers for tissue engineering |
US20020022859A1 (en) * | 1999-03-12 | 2002-02-21 | Michael Hogendijk | Catheter having radially expandable main body |
US6867247B2 (en) * | 1999-03-25 | 2005-03-15 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
US6838493B2 (en) * | 1999-03-25 | 2005-01-04 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
US6348041B1 (en) * | 1999-03-29 | 2002-02-19 | Cook Incorporated | Guidewire |
US6206907B1 (en) * | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6712836B1 (en) * | 1999-05-13 | 2004-03-30 | St. Jude Medical Atg, Inc. | Apparatus and methods for closing septal defects and occluding blood flow |
US6206895B1 (en) * | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6344049B1 (en) * | 1999-08-17 | 2002-02-05 | Scion Cardio-Vascular, Inc. | Filter for embolic material mounted on expandable frame and associated deployment system |
US6358238B1 (en) * | 1999-09-02 | 2002-03-19 | Scimed Life Systems, Inc. | Expandable micro-catheter |
US6712804B2 (en) * | 1999-09-20 | 2004-03-30 | Ev3 Sunnyvale, Inc. | Method of closing an opening in a wall of the heart |
US20030059640A1 (en) * | 1999-11-19 | 2003-03-27 | Denes Marton | High strength vacuum deposited nitinol alloy films and method of making same |
US20020010481A1 (en) * | 1999-12-23 | 2002-01-24 | Swaminathan Jayaraman | Occlusive coil manufacture and delivery |
US20020026208A1 (en) * | 2000-01-05 | 2002-02-28 | Medical Technology Group, Inc. | Apparatus and methods for delivering a closure device |
US20020019648A1 (en) * | 2000-04-19 | 2002-02-14 | Dan Akerfeldt | Intra-arterial occluder |
US6214029B1 (en) * | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6352552B1 (en) * | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
US6867249B2 (en) * | 2000-08-18 | 2005-03-15 | Kin Man Amazon Lee | Lightweight and porous construction materials containing rubber |
US20020022860A1 (en) * | 2000-08-18 | 2002-02-21 | Borillo Thomas E. | Expandable implant devices for filtering blood flow from atrial appendages |
US20020029048A1 (en) * | 2000-09-01 | 2002-03-07 | Arnold Miller | Endovascular fastener and grafting apparatus and method |
US20020034259A1 (en) * | 2000-09-21 | 2002-03-21 | Katsuyuki Tada | Transmitter for automatically changing transmission data type within specified band |
US20020035374A1 (en) * | 2000-09-21 | 2002-03-21 | Borillo Thomas E. | Apparatus for implanting devices in atrial appendages |
US6508828B1 (en) * | 2000-11-03 | 2003-01-21 | Radi Medical Systems Ab | Sealing device and wound closure device |
US20030057156A1 (en) * | 2001-03-08 | 2003-03-27 | Dean Peterson | Atrial filter implants |
US20030004533A1 (en) * | 2001-05-04 | 2003-01-02 | Concentric Medical | Bioactive polymer vaso-occlusive device |
US20030023266A1 (en) * | 2001-07-19 | 2003-01-30 | Borillo Thomas E. | Individually customized atrial appendage implant device |
US20030028213A1 (en) * | 2001-08-01 | 2003-02-06 | Microvena Corporation | Tissue opening occluder |
US20030045893A1 (en) * | 2001-09-06 | 2003-03-06 | Integrated Vascular Systems, Inc. | Clip apparatus for closing septal defects and methods of use |
US20030050665A1 (en) * | 2001-09-07 | 2003-03-13 | Integrated Vascular Systems, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20030055455A1 (en) * | 2001-09-20 | 2003-03-20 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
US20050025809A1 (en) * | 2003-07-08 | 2005-02-03 | Tepha, Inc. | Poly-4-hydroxybutyrate matrices for sustained drug delivery |
US20050043759A1 (en) * | 2003-07-14 | 2005-02-24 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US20070010851A1 (en) * | 2003-07-14 | 2007-01-11 | Chanduszko Andrzej J | Tubular patent foramen ovale (PFO) closure device with catch system |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11369374B2 (en) | 2006-05-03 | 2022-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US10595861B2 (en) | 2006-05-03 | 2020-03-24 | Datascope Corp. | Systems and methods of tissue closure |
US9375218B2 (en) | 2006-05-03 | 2016-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US20100234878A1 (en) * | 2009-03-16 | 2010-09-16 | Cook Incorporated | Closure device with string retractable umbrella |
US8029534B2 (en) | 2009-03-16 | 2011-10-04 | Cook Medical Technologies Llc | Closure device with string retractable umbrella |
US8277482B2 (en) | 2009-03-16 | 2012-10-02 | Cook Medical Technologies Llc | Closure device with string retractable umbrella and method for closing a body opening with the same |
US9259290B2 (en) | 2009-06-08 | 2016-02-16 | MRI Interventions, Inc. | MRI-guided surgical systems with proximity alerts |
US9439735B2 (en) | 2009-06-08 | 2016-09-13 | MRI Interventions, Inc. | MRI-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real time |
US8886288B2 (en) | 2009-06-16 | 2014-11-11 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US8825133B2 (en) | 2009-06-16 | 2014-09-02 | MRI Interventions, Inc. | MRI-guided catheters |
US8768433B2 (en) | 2009-06-16 | 2014-07-01 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US8396532B2 (en) | 2009-06-16 | 2013-03-12 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US8369930B2 (en) | 2009-06-16 | 2013-02-05 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US10485545B2 (en) | 2013-11-19 | 2019-11-26 | Datascope Corp. | Fastener applicator with interlock |
US11564689B2 (en) | 2013-11-19 | 2023-01-31 | Datascope Corp. | Fastener applicator with interlock |
US11653928B2 (en) | 2018-03-28 | 2023-05-23 | Datascope Corp. | Device for atrial appendage exclusion |
US20210205006A1 (en) * | 2020-01-07 | 2021-07-08 | Virender K. Sharma | Methods and Devices for Endoscopic Resection |
EP4087507A4 (en) * | 2020-01-07 | 2024-02-14 | Virender K Sharma | Methods and devices for endoscopic resection |
Also Published As
Publication number | Publication date |
---|---|
EP1471835A2 (en) | 2004-11-03 |
CA2471871A1 (en) | 2003-07-24 |
WO2003059152A3 (en) | 2003-11-13 |
AU2003210510A1 (en) | 2003-07-30 |
US7220265B2 (en) | 2007-05-22 |
EP1471835A4 (en) | 2008-03-19 |
JP2005525843A (en) | 2005-09-02 |
US20030144694A1 (en) | 2003-07-31 |
WO2003059152A2 (en) | 2003-07-24 |
AU2003210510A8 (en) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7220265B2 (en) | Patent foramen ovale (PFO) closure method and device | |
US7967840B2 (en) | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance | |
US9017373B2 (en) | Septal closure devices | |
US7717937B2 (en) | Closure devices, related delivery methods and tools, and related methods of use | |
US20040143294A1 (en) | Septal stabilization device | |
AU2007303461B2 (en) | Single disc intraluminal fixation patent foramen ovale closure device | |
US20040098121A1 (en) | Patent foramen ovale (PFO) closure with magnetic force | |
JP2009512521A (en) | Radiopaque bioabsorbable occluder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: W.L. GORE & ASSOCIATES, INC., ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NMT MEDICAL, INC. (BY AND THROUGH JOSEPH F. FINN, JR., AS ASSIGNEE FOR THE BENEFIT OF CREDITORS OF NMT MEDICAL, INC.);REEL/FRAME:026503/0273 Effective date: 20110616 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |